Nearly 3.6 million ordinary shares in Advanced Medical Solutions Group Plc traded across a tight price band on Monday, drawing mandatory regulatory scrutiny under UK takeover rules.
The shares moved within a range of 282.5p to 283p, with the spread between the lowest and highest prices across both purchase and sale transactions amounting to just half a penny.
Investec Bank Plc, acting as an exempt principal trader with recognised intermediary status, executed the transactions on 2 November 2026 in a client-serving capacity.
On the purchase side, Investec acquired 1,799,415 ordinary shares at prices ranging from 282.5p to a high of 282.75p per unit during the session.
Sales of 1,813,805 ordinary shares were also recorded, with the top price achieved reaching 283p and the floor matching the purchase low at 282.5p.
The filing, submitted to a Regulatory Information Service on 3 November 2026, was made under Rule 8.5 of the UK Takeover Code, which governs dealing disclosures by exempt principal traders.
Investec’s position in this situation carries additional significance given that the bank serves as both Advisor and Joint Broker to Advanced Medical Solutions Group Plc in connection with the offer.
That dual role requires Investec to report its market-making and client-driven activity separately from any advisory function, ensuring transparency around potential conflicts during a live offer period.
The disclosure confirms that no cash-settled or stock-settled derivative transactions were undertaken, and no options were written, purchased, or exercised in relation to AMS.L shares on that date.
Investec also confirmed the absence of any indemnity arrangements, formal or informal agreements relating to voting rights, or understandings concerning the future acquisition or disposal of securities referenced by derivatives.
The filing noted the offer is treated as a cash offer or possible cash offer, making disclosures in respect of any other party to the transaction not applicable in this instance.
Advanced Medical Solutions Group Plc, traded on the London Stock Exchange under the ticker AMS.L, specialises in advanced wound care and surgical products, operating across multiple international markets.
Regulatory filings of this kind provide market participants and the Takeover Panel’s Market Surveillance Unit with a real-time window into trading activity surrounding companies involved in potential corporate transactions.
